Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study
tazemetostat(一种 EZH2 抑制剂)治疗中国复发/难治性滤泡性淋巴瘤患者的疗效和安全性:一项多中心、单臂 II 期研究
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103399
Cao, Junning; Chen, Guangliang; Qiu, Lihua; Zhang, Liling; Jiang, Ming; Cheng, Ying; Zhang, Qiaohua; Liu, Lihong; Li, Ping; Shuang, Yuerong; Wang, Huaqing; Xue, Hongwei; Wu, Huijing; Zheng, Meifang; Zhou, Keshu; Li, Zhiming; Jing, Hongmei; Yang, Wei; Zhu, Zunmin; Li, Wenyu; Wangwu, Jiaxuan; Huang, Heyu; Jia, Qiantao; Chen, Dongmei; Fan, Songhua; Shi, M Ming; Su, Weiguo